We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Smith & Wesson
SWBI
$644M
| $570K | ﹤0.01% |
58,282
+8,782
| +18% | +$84K |
|
|
IPHI
2227
DELISTED
INPHI CORPORATION
IPHI
| $569K | ﹤0.01% |
31,929
+4,850
| +18% | +$91.1K |
|
2228
GoPro
GPRO
$125M
| $566K | ﹤0.01% |
13,035
+50
| +0.4% | +$2.36K |
|
|
BMTC
2229
DELISTED
Bryn Mawr Bank Corp
BMTC
| $565K | ﹤0.01% |
18,589
+500
| +3% | +$15K |
|
|
TAHO
2230
DELISTED
Tahoe Resources Inc
TAHO
| $565K | ﹤0.01% |
51,583
+440
| +0.9% | +$5.85K |
|
|
REV
2231
DELISTED
Revlon, Inc.
REV
| $565K | ﹤0.01% |
13,706
+600
| +5% | +$20.8K |
|
2232
American Vanguard Corp
AVD
$72.1M
| $564K | ﹤0.01% |
53,144
+2,000
| +4% | +$22.3K |
|
|
SD
2233
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $562K | ﹤0.01% |
315,775
-4,950
| -2% | -$8.32K |
|
|
PHIIK
2234
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $562K | ﹤0.01% |
18,683
+1,000
| +6% | +$33.3K |
|
|
SFE
2235
DELISTED
Safeguard Scientifics, Inc.
SFE
| $558K | ﹤0.01% |
30,873
+1,600
| +5% | +$29.6K |
|
2236
ANI Pharmaceuticals
ANIP
$1.76B
| $557K | ﹤0.01% |
8,910
+2,200
| +33% | +$134K |
|
|
GPX
2237
DELISTED
GP Strategies Corp.
GPX
| $557K | ﹤0.01% |
15,043
+1,300
| +9% | +$44.8K |
|
|
XNPT
2238
DELISTED
XENOPORT, INC.
XNPT
| $556K | ﹤0.01% |
78,118
+5,200
| +7% | +$40.3K |
|
2239
Enterprise Financial Services Corp
EFSC
$2.4B
| $555K | ﹤0.01% |
26,862
+1,500
| +6% | +$30K |
|
|
CALD
2240
DELISTED
Callidus Software, Inc.
CALD
| $555K | ﹤0.01% |
43,773
+9,400
| +27% | +$137K |
|
|
ALJ
2241
DELISTED
Alon USA Energy Inc
ALJ
| $555K | ﹤0.01% |
33,497
+300
| +0.9% | +$3.97K |
|
|
OB
2242
DELISTED
Onebeacon Insurance Group Ltd
OB
| $555K | ﹤0.01% |
36,505
+1,500
| +4% | +$23.4K |
|
|
HK
2243
DELISTED
Halcon Resources Corporation
HK
| $554K | ﹤0.01% |
2,088
+115
| +6% | +$34K |
|
|
ANAT
2244
DELISTED
American National Group, Inc. Common Stock
ANAT
| $552K | ﹤0.01% |
5,613
+264
| +5% | +$27.2K |
|
2245
First Bancorp
FBNC
$2.66B
| $551K | ﹤0.01% |
31,366
+1,500
| +5% | +$25.9K |
|
2246
Onto Innovation
ONTO
$15B
| $551K | ﹤0.01% |
32,756
+2,500
| +8% | +$42.8K |
|
2247
Perdoceo Education
PRDO
$2.13B
| $551K | ﹤0.01% |
109,475
+4,000
| +4% | +$23.1K |
|
|
VWTR
2248
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $551K | ﹤0.01% |
33,988
+1,500
| +5% | +$25K |
|
2249
Sarepta Therapeutics
SRPT
$1.76B
| $549K | ﹤0.01% |
41,357
+7,475
| +22% | +$99.6K |
|
|
SCLN
2250
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $548K | ﹤0.01% |
61,807
+7,400
| +14% | +$58.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.